Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06XXW
|
||||
| Former ID |
DIB003784
|
||||
| Drug Name |
NRX-1074
|
||||
| Indication | Major depressive disorder [ICD9: 296.2, 296.3, 710.0; ICD10:F32, F33, M32] | Phase 2 | [1] | ||
| Company |
Naurex
|
||||
| Structure |
|
Download2D MOL |
|||
| Target and Pathway | |||||
| Target(s) | NMDA receptor | Target Info | Agonist | [2] | |
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT02067793) Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder. U.S. National Institutes of Health. | ||||
| REF 2 | Neuroplasticity and the next wave of antidepressant strategies. Front Cell Neurosci. 2013 Nov 20;7:218. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.